Bionano Genomics (BNGO) Competitors $0.20 -0.01 (-2.74%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BNGO vs. OWLT, MASS, OPXS, OPTX, CLIR, PRE, OMIC, MSAI, AATC, and RPIDShould you be buying Bionano Genomics stock or one of its competitors? The main competitors of Bionano Genomics include Owlet (OWLT), 908 Devices (MASS), Optex Systems (OPXS), Syntec Optics (OPTX), ClearSign Technologies (CLIR), Prenetics Global (PRE), Singular Genomics Systems (OMIC), MultiSensor AI (MSAI), Autoscope Technologies (AATC), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry. Bionano Genomics vs. Owlet 908 Devices Optex Systems Syntec Optics ClearSign Technologies Prenetics Global Singular Genomics Systems MultiSensor AI Autoscope Technologies Rapid Micro Biosystems Owlet (NYSE:OWLT) and Bionano Genomics (NASDAQ:BNGO) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership. Do insiders & institutionals believe in OWLT or BNGO? 72.6% of Owlet shares are owned by institutional investors. Comparatively, 11.4% of Bionano Genomics shares are owned by institutional investors. 67.1% of Owlet shares are owned by insiders. Comparatively, 1.6% of Bionano Genomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, OWLT or BNGO? Owlet has higher revenue and earnings than Bionano Genomics. Owlet is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwlet$78.58M0.95-$32.90M-$2.39-1.94Bionano Genomics$33.33M0.60-$232.49M-$2.32-0.08 Do analysts rate OWLT or BNGO? Bionano Genomics has a consensus price target of $1.50, suggesting a potential upside of 669.23%. Given Bionano Genomics' stronger consensus rating and higher probable upside, analysts plainly believe Bionano Genomics is more favorable than Owlet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owlet 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility & risk, OWLT or BNGO? Owlet has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500. Comparatively, Bionano Genomics has a beta of 2.28, indicating that its share price is 128% more volatile than the S&P 500. Does the media refer more to OWLT or BNGO? In the previous week, Owlet had 1 more articles in the media than Bionano Genomics. MarketBeat recorded 3 mentions for Owlet and 2 mentions for Bionano Genomics. Bionano Genomics' average media sentiment score of 0.44 beat Owlet's score of 0.11 indicating that Bionano Genomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bionano Genomics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is OWLT or BNGO more profitable? Owlet has a net margin of -13.23% compared to Bionano Genomics' net margin of -407.34%. Owlet's return on equity of 0.00% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Owlet-13.23% N/A -8.42% Bionano Genomics -407.34%-154.45%-80.78% Does the MarketBeat Community favor OWLT or BNGO? Bionano Genomics received 158 more outperform votes than Owlet when rated by MarketBeat users. Likewise, 64.03% of users gave Bionano Genomics an outperform vote while only 16.67% of users gave Owlet an outperform vote. CompanyUnderperformOutperformOwletOutperform Votes416.67%Underperform Votes2083.33% Bionano GenomicsOutperform Votes16264.03% Underperform Votes9135.97% SummaryOwlet beats Bionano Genomics on 9 of the 17 factors compared between the two stocks. Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNGO vs. The Competition Export to ExcelMetricBionano GenomicsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.45M$5.42B$5.13B$9.07BDividend YieldN/A0.43%5.08%4.23%P/E Ratio-0.0825.1889.5817.17Price / Sales0.604.291,116.12116.95Price / CashN/A44.4542.8237.86Price / Book0.092.204.774.78Net Income-$232.49M$2.05M$120.15M$225.60M7 Day Performance-18.72%-2.70%-1.92%-1.23%1 Month Performance-8.11%-2.89%11.47%3.36%1 Year Performance-87.96%-28.70%30.52%16.60% Bionano Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNGOBionano Genomics1.185 of 5 stars$0.20-2.7%$1.50+669.2%-88.0%$20.45M$33.33M-0.08300OWLTOwlet1.5309 of 5 stars$4.96+0.6%N/A-18.2%$79.56M$54M-2.06106News CoverageMASS908 Devices1.9102 of 5 stars$2.18+4.8%$8.00+267.0%-76.3%$75.91M$55.16M-1.2960News CoverageOPXSOptex Systems2.6771 of 5 stars$9.10+9.6%N/A+60.9%$62.52M$25.66M13.61122Earnings ReportNews CoverageOPTXSyntec Optics0.2886 of 5 stars$1.51+53.5%N/A-32.6%$55.50M$29.44M0.003News CoverageGap DownHigh Trading VolumeCLIRClearSign Technologies3.386 of 5 stars$1.10-5.4%$6.00+446.8%-4.2%$55.11M$2.40M-10.5510Analyst ForecastShort Interest ↓PREPrenetics Global1.9644 of 5 stars$5.90-0.7%$9.00+52.5%+14.9%$53.91M$25.56M-1.491Gap UpOMICSingular Genomics Systems1.2208 of 5 stars$20.18+0.9%$10.75-46.7%+59.3%$50.65M$2.91M0.00220Negative NewsMSAIMultiSensor AI3.5486 of 5 stars$1.49-2.6%$8.00+436.9%N/A$45.36M$7.62M0.0035Gap UpAATCAutoscope TechnologiesN/A$8.00flatN/A+13.7%$43.79M$12.89M9.0940RPIDRapid Micro Biosystems2.2062 of 5 stars$1.00+0.2%N/A-4.3%$43.14M$22.52M-0.89193Gap Up Related Companies and Tools Related Companies OWLT Alternatives MASS Alternatives OPXS Alternatives OPTX Alternatives CLIR Alternatives PRE Alternatives OMIC Alternatives MSAI Alternatives AATC Alternatives RPID Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BNGO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
